High-energy focussed extracorporeal shockwave therapy reduces pain in plantar fibromatosis (Ledderhose’s disease)

BMC Research Notes

Peter M Vogt¹  Karsten Knobloch² 

[1] Plastic, Hand- and Reconstructive Surgery, Hannover Medical School, Hannover Germany;Plastic, Hand and Reconstructive Surgery, Burn Center, Hannover Medical School, Carl-Neuberg-Str. 1, Hannover 30625, Germany

关键词: Pain;    Ledderhose;    Fibromatosis;    Extracorporeal shockwave therapy (ESWT);   

Others  :  1165549
DOI  :  10.1186/1756-0500-5-542

 received in 2012-03-13, accepted in 2012-09-26,  发布年份 2012

【 摘 要 】

Background

Plantar fibromatosis is a benign disease creating nodules on the medial plantar side of affected patients. While surgical removal is regarded as the therapeutic mainstay, recurrence rates and impairment of daily activities remains substantial. High-energy focussed extracorporeal shockwave therapy has been suggested to be potentially effective in plantar fibromatosis in terms of pain reduction.

Hypothesis

High-energy focussed extracorporeal shockwave therapy reduces pain in plantar fibromatosis.

Findings

A total number of six patients (5 males, 58±4 years) were included with plantar fibromatosis (Ledderhose’s disease) associated with pain. Three patients were operated on previously, one had concomitant Dupuytren’s contracture. High-energy focussed ESWT was applied using a Storz Duolith SD1 (2000 impulses, 3 Hz, 1.24 mJ/mm2) in two sessions with 7 days between. Pain was 6±2 at baseline, 2±1 after 14 days and 1±1 after 3 months. Softening of the nodules was noted by all patients. No adverse effects were noted.

Conclusions

High-energy focussed extracorporeal shockwave energy reduces pain in painful plantar fibromatosis (Morbus Ledderhose). Further large-scale prospective trials are warranted to elucidate the value of high-energy focussed extracorporeal shockwave therapy (ESWT) in plantar fibromatosis in terms of recurrence and efficacy.

【 授权许可】

   
2012 Knobloch and Vogt; licensee BioMed Central Ltd.

【 图 表 】

Figure 1.

Figure 2.

Figure 3.

【 参考文献 】

• [1]Zgonis T, Jolly GP, Plyzois V, Kanuck DM, Stamatis ED: Plantar fibromatosis. Clin Podiatr Med Surg 2005, 22(1):11-18.
• [2]Van der Veer WM, Hamburg SM, de Gast A, Niessen FB: Recurrence of plantar fibromatosis after plantar fasciectomy: single-center long-term results. Plast Reconstr Surg 2008, 122(2):486-491.
• [3]De Bree E, Zoetmulder FA, Keus RB, Peterse HL, van Coevorden F: Incidence and treatment of recurrent plantar fibromatosis by surgery and postoperative radiotherapy. Am J Surg 2004, 187(1):33-38.
• [4]Seegenschmiedt MH, Attassi M: Radiation therapy for Morbus Ledderhose – indication and clinical results. Strahlenther Onkol 2003, 179(12):847-853.
• [5]Palmieri A, Imbimbo C, Longo N, Fusco P, Verze F, Mangiopia F, et al.: A first prospective, randomized, double-blind, placebo-controlled clinical trial evaluating extracorporal shock wave therapy for the treatment of Peyronie’s disease. Eur Urol 2009, 56(2):363-369.
• [6]Srirangam SJ, Manikandan R, Hussain J, Collins GN, O’Reilly PH: Long-term results of extracorporeal shockwave therapy for Peyronie’s disease. J Endourol 2006, 20(11):880-884.
• [7]Knobloch K, Kuehn M, Vogt PM: Focussed extracorporeal shockwave therapy in Dupuytren’s disease-a hypothesis. Med Hypotheses 2011, 76(5):635-637.